NeuroVice Launches a Groundbreaking Device for Seizure Management
In a significant advancement for seizure management, NeuroVice has introduced PATI, the first FDA-cleared medical device designed specifically to protect against oral injuries and assist with airway management during seizures. This product debut will take place at a prominent annual meeting focused on epilepsy, marking a transformative moment for patients and caregivers alike.
The Need for Innovative Seizure Protection
Epilepsy affects millions globally, highlighting the urgent need for effective solutions. With approximately 65 million people living with this neurological condition worldwide, NeuroVice's PATI comes to address a critical gap in care. Traditionally, emergency protocols limited responses during seizures, leaving many individuals exposed to unnecessary risks.
From Concept to Reality: A Patient-Centered Approach
Dr. Ashlyn Sanders, the driving force behind NeuroVice and its innovative device, understands the struggles of living with seizures firsthand. After her own experiences as a pediatric neurology resident at Johns Hopkins, she realized the deficiencies in existing care methods. Dr. Sanders states, "PATI encapsulates the merging of clinical and personal insights, aiming to provide patients with the safety they deserve during seizure events." This dedication results in a device that is not just functional but also deeply empathetic to the patient experience.
PATI: A Revolutionary Breakthrough in Seizure Care
PATI is designed with distinctive features that set it apart from improvised solutions that have often resulted in additional harm. Key components include:
- **Tongue cradles** preventing injuries during seizures.
- **Strong bite pads** that shield teeth effectively.
- A **lip guard** to protect sensitive tissues.
- A central opening for maintaining airway access and facilitating medication delivery.
- **Ergonomic handles** designed for rapid response in emergencies.
This design ensures PATI can be used easily by healthcare professionals as well as caregivers and trained family members, regardless of their experience level.
Empowering Patients and Caregivers
PATI is designed for individuals aged 12 and older, making it a versatile option for various seizure types. This device not only complements conventional seizure medications but is also indicated for cases where typical treatments fall short. By broadening the horizons of seizure management, NeuroVice is encouraging a proactive approach to patient safety.
The Response from the Medical Community
The response to PATI from neurologists, epilepsy specialists, and patient advocates has been overwhelmingly positive. CEO Jordan Schindler highlights the importance of bridging existing gaps in seizure protocols, stating, "This device signifies a move from a reactionary approach to one centered on proactive safety. We're ensuring that all patients have access to effective and safe seizure management strategies."
A Mission Rooted in Personal Experience
NeuroVice's mission extends far beyond product innovation; it is intrinsically tied to the experiences of those impacted by seizures. With a team that shares a personal connection to seizure disorders, the organization forms strategic partnerships that aim to reshape the standard of care. Together, they are committing to not only address immediate patient needs but also influence future guidelines in healthcare.
Learn More About NeuroVice and Its Commitment to Seizure Care
NeuroVice remains dedicated to enhancing patient outcomes and providing innovative solutions in seizure management. Through collaborations and the invaluable support of individuals who understand these challenges, the company is driving impactful changes. As they continue to enhance their offerings, they welcome inquiries and discussions to further their mission in transforming care standards.
Frequently Asked Questions
What is PATI?
PATI is a patented seizure rescue device designed to protect against oral injuries and assist with airway management during seizures.
Who developed PATI?
PATI was developed by Dr. Ashlyn Sanders, a pediatric neurology resident at Johns Hopkins who created it based on her personal experiences with seizures.
What features make PATI unique?
PATI includes several unique features, like tongue cradles, strong bite pads, and ergonomic handles for easy use during seizures.
Is PATI available for all ages?
PATI is designed for individuals aged 12 and older, accommodating a variety of seizure types.
How can someone obtain PATI?
PATI is available by prescription through designated medical channels, including platforms that facilitate patient access.
